HomeAI · summaries
Storia in 3 fonti
Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada
Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providing treatment for type 2 diabetes. Canada is the first G7 nation to approve this medication. The launch follows a recent introduction in India. Dr Reddy's aims to expand access to these therapies globally.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business pressures. However, operations in India,…
- ·
thehindubusinessline.com
Dr Reddy’s launches its generic Semaglutide injection in Canada
Dr. Reddy’s launches generic Semaglutide Injection in Canada, marking the first G7 approval for this diabetes treatment.
